Eli Lilly and Company v. Novartis Pharma AG
| ELI LILLY AND COMPANY, ELI LILLY ITALIA S.P.A., ELI LILLY KINSALE LIMITED, ELI LILLY GES.M.B.H. and ELI LILLY NEDERLAND B.V. |
| NOVARTIS PHARMA AG |
| 22-1094 |
| February 2, 2022 |
| U.S. Court of Appeals, Fourth Circuit |
| Other Statutory Actions |
Opinions
We have the following opinions for this case:
| Description |
|---|
 Eli Lilly and Company v. Novartis Pharma AG
|
Docket Report
RSS Track this Docket
This docket was last retrieved on March 31, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 32 Certification of compliance with argument protocol by Novartis Pharma AG. Certification of compliance uploaded for William Jay. [1001138534] [22-1094] PSC [Entered: 03/31/2022 06:46 PM] |
| Filing 31 Certification of compliance with argument protocol by Novartis Pharma AG. Certification of compliance uploaded for Jordan Bock. [1001138526] [22-1094] PSC [Entered: 03/31/2022 06:05 PM] |
| Filing 30 Calendar notice sent. AMENDED ORAL ARGUMENT NOTIFICATION. Date: 05/04/2022. Session Starting Time: 9:30 AM. Check-in Time: 10:30 AM. [1001136693] [22-1094]--[Edited 03/29/2022 by SCC to correct text] SCC [Entered: 03/29/2022 04:18 PM] |
| Filing 29 Receipt of paper copy of RESPONSE BRIEF filed at [ # 28 ] by Novartis Pharma AG. Number of pages: [65]. Sufficient: YES. Number of Copies: [4]. Received by clerk date: 03/29/2022. [1001136386] [22-1094] KH [Entered: 03/29/2022 12:30 PM] |
| Filing 28 BRIEF by Novartis Pharma AG. Type of Brief: RESPONSE. [1001134748] [22-1094] William Jay [Entered: 03/25/2022 11:55 PM] |
| Filing 27 APPEARANCE OF COUNSEL by Jordan Bock for Novartis Pharma AG. [1001133433] [22-1094] Jordan Bock [Entered: 03/24/2022 10:25 AM] |
| Filing 25 ORAL ARGUMENT ACKNOWLEDGMENT by Novartis Pharma AG. Counsel arguing: William M. Jay. Answering argument time: 20 minutes. .. [1001130532] [22-1094] William Jay [Entered: 03/18/2022 01:19 PM] |
| Filing 24 ORAL ARGUMENT ACKNOWLEDGMENT by Eli Lilly and Company, Eli Lilly Ges.m.b.H., Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited and Eli Lilly Nederland B.V.. Counsel arguing: Katherine A. Helm. Opening argument time: 13 minutes. Rebuttal argument time: 7 minutes. .. [1001130478] [22-1094] Katherine Helm [Entered: 03/18/2022 12:10 PM] |
| Filing 23 CASE CALENDARED for oral argument. Date: 05/04/2022. SEE AMENDED ORAL ARGUMENT NOTIFICATION FOR COURTHOUSE PROTOCOLS AND CHECK-IN TIMES. [1001126260] [22-1094]--[Edited 03/30/2022 by SCC] JLC [Entered: 03/11/2022 03:14 PM] |
| Filing 22 Receipt of paper copy of APPENDIX filed at [ # 20 ], [ # 19 ] by Eli Lilly Ges.m.b.H., Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited, Eli Lilly Nederland B.V. and Eli Lilly and Company. Total number of volumes (including any sealed): [2]. Total number of pages in all volumes: [818]. Total number of sealed volumes: 0. Sufficient? Yes. CD/DVD/Other exhibit? No. Number of copies: [4]. Received by clerk date: 03/04/2022. [1001121633] [22-1094] TW [Entered: 03/04/2022 11:30 AM] |
| Filing 21 Receipt of paper copy of OPENING BRIEF filed at [ # 18 ] by Eli Lilly Ges.m.b.H., Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited, Eli Lilly Nederland B.V. and Eli Lilly and Company. Number of pages: [70]. Sufficient: Yes. Number of copies: [4]. Received by clerk date: 03/04/2022. [1001121632] [22-1094] TW [Entered: 03/04/2022 11:29 AM] |
| Filing 20 JOINT APPENDIX by Eli Lilly and Company, Eli Lilly Ges.m.b.H., Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited and Eli Lilly Nederland B.V.. Digital media exhibit volume? No. [1001120658] [22-1094] Katherine Helm [Entered: 03/02/2022 08:14 PM] |
| Filing 19 JOINT APPENDIX by Eli Lilly and Company, Eli Lilly Ges.m.b.H., Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited and Eli Lilly Nederland B.V.. Digital media exhibit volume? No. [1001120657] [22-1094] Katherine Helm [Entered: 03/02/2022 08:10 PM] |
| Filing 18 BRIEF by Eli Lilly and Company, Eli Lilly Ges.m.b.H., Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited and Eli Lilly Nederland B.V.. Type of Brief: OPENING. [1001120656] [22-1094] Katherine Helm [Entered: 03/02/2022 07:43 PM] |
| Filing 17 NOTICE REGARDING CONFLICT WITH PROPOSED ARGUMENT DATES by Appellee Novartis Pharma AG. Argument Session: 05/22. Days you are available: May 4-5, 2022.. . [1001118587] [22-1094] William Jay [Entered: 02/28/2022 04:10 PM] |
| Filing 16 Amended BRIEFING ORDER filed (amending Reply Brief deadline). Opening Brief and Appendix due 03/02/2022. Response Brief due 03/25/2022. Counsel shall file four paper copies of their briefs and appendices when filing the electronic versions. [1001116640] [22-1094] CB [Entered: 02/24/2022 01:53 PM] |
| Filing 15 CASE TENTATIVELY CALENDARED for oral argument during the May 3-5, 2022 argument session. Counsel shall file four paper copies of their briefs and appendices when filing the electronic versions. Notify Clerk's Office of any scheduling conflict by: 02/28/2022. [1001116572] [22-1094] PSC [Entered: 02/24/2022 12:39 PM] |
| Filing 14 (ENTRY RESTRICTED) Accelerated BRIEFING ORDER filed. Opening Brief and Appendix due 03/02/2022. Response Brief due 03/25/2022. Paper copy requirements are temporarily suspended unless the case is under pre-argument review or being scheduled for argument, in which case a total of four paper copies of formal briefs and appendices are required. [1001114716] [22-1094]--[Edited 02/24/2022 by CB - - see ECF 16 for amended briefing order.] CB [Entered: 02/22/2022 04:06 PM] |
Filing 13
ORDER filed granting Motion to expedite case processing [ # 12 ]; administratively terminating Motion to expedite [ # 7 ]. Copies to all parties. [1001114698] [22-1094] CB [Entered: 02/22/2022 03:52 PM]
|
| Filing 12 CONSENT/STIPULATION by Eli Lilly and Company, Eli Lilly Ges.m.b.H., Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited and Eli Lilly Nederland B.V. to expedite decision [1001114427] [22-1094] Katherine Helm [Entered: 02/22/2022 12:30 PM] |
| Filing 11 RESPONSE/ANSWER by Novartis Pharma AG to Motion to expedite decision [ # 7 ], notice requesting response [ # 8 ]. Nature of response: in opposition. [1001113745] [22-1094] William Jay [Entered: 02/18/2022 09:55 PM] |
| Filing 10 APPEARANCE OF COUNSEL by Katherine A. Helm for Eli Lilly and Company, Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited, Eli Lilly Ges.m.b.H. and Eli Lilly Nederland B.V.. [1001110671] [22-1094] Katherine Helm [Entered: 02/15/2022 11:46 AM] |
| Filing 9 DISCLOSURE STATEMENT by Novartis Pharma AG. Was any question on Disclosure Form answered yes? Yes [1001110584] [22-1094] William Jay [Entered: 02/15/2022 10:49 AM] |
| Filing 8 NOTICE ISSUED to Novartis Pharma AG requesting response to Motion to expedite decision [ # 7 ]. Response due 02/18/2022. Mailed to: Christopher Essig, Patrick O'Meara and Jovial Wong. [1001109441] [22-1094] CB [Entered: 02/14/2022 08:51 AM] |
| Filing 7 MOTION by Eli Lilly and Company, Eli Lilly Ges.m.b.H., Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited and Eli Lilly Nederland B.V. to expedite decision. Date and method of service: 02/11/2022 ecf. [1001109330] [22-1094] Christina Sarchio [Entered: 02/11/2022 07:15 PM] |
| Filing 6 DISCLOSURE STATEMENT by Eli Lilly and Company, Eli Lilly Ges.m.b.H., Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited and Eli Lilly Nederland B.V.. Was any question on Disclosure Form answered yes? Yes [1001109329] [22-1094] Christina Sarchio [Entered: 02/11/2022 07:13 PM] |
| Filing 5 DOCKETING STATEMENT by Eli Lilly and Company, Eli Lilly Ges.m.b.H., Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited and Eli Lilly Nederland B.V... [1001109328] [22-1094] Christina Sarchio [Entered: 02/11/2022 07:12 PM] |
| Filing 4 APPEARANCE OF COUNSEL by Christina Guerola Sarchio for Eli Lilly and Company, Eli Lilly Italia S.p.A., Eli Lilly Kinsale Limited, Eli Lilly Ges.m.b.H. and Eli Lilly Nederland B.V.. [1001109327] [22-1094] Christina Sarchio [Entered: 02/11/2022 07:10 PM] |
| Filing 3 APPEARANCE OF COUNSEL by William M. Jay for Novartis Pharma AG. [1001107498] [22-1094] William Jay [Entered: 02/09/2022 03:00 PM] |
| Filing 2 DOCKETING NOTICE issued Re: [ # 1 ] case. Originating case number: 1:21-mc-00017-TSE-IDD. Mailed to: Christopher Essig, Sharon Gagliardi, Katherine Helm, Patrick O'Meara, Luke M. Reilly and Jovial Wong. [1001102790] [22-1094] CB [Entered: 02/02/2022 10:09 AM] |
| Filing 1 Case docketed. Originating case number: 1:21-mc-00017-TSE-IDD. Case manager: CBennett. [1001102784] [22-1094] CB [Entered: 02/02/2022 10:01 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
